| RLYB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the RLYB shares outstanding history going back to 9/8/2021:
Also see: RLYB Market Cap History RLYB YTD Return |
As of 3/6/2026 Rallybio has 5.29 million RLYB shares outstanding. Investors often track the RLYB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RLYB share count trends over time, with 18 historical shares outstanding datapoints presented, dating back to 9/8/2021.

| RLYB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the RLYB shares outstanding history going back to 9/8/2021:
Also see: RLYB Market Cap History RLYB YTD Return |
| RLYB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||
RLYB Historical Shares Outstanding: +6.32% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| RLYB Stock Price Chart |
| About Rallybio Corp |
| Rallybio Corporation is a clinical-stage biotech company focused on developing therapies for severe and rare diseases. Their pipeline targets unmet medical needs in maternal fetal health, complement dysregulation, hematology, and metabolic disorders. They have two clinical-stage programs: RLYB212, an anti-HPA-1a antibody for preventing fetal and neonatal alloimmune thrombocytopenia (FNAIT), and RLYB116, a complement component 5 (C5) inhibitor for treating complement dysregulation diseases. Other candidates include RLYB114, a C5-targeted molecule for ophthalmic diseases, RLYB331 for severe anemia, and the ENPP1 program. We show 18 historical shares outstanding datapoints in our coverage of RLYB's shares outstanding history. Understanding the changing numbers of RLYB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RLYB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RLYB by allowing them to research RLYB shares outstanding history as well as any other stock in our coverage universe. |
| RLYB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RLYB Share Performance |
| Shares Outstanding Peers |
| Rallybio (RLYB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History RNA Shares Outstanding History RNAC Shares Outstanding History RNAZ Shares Outstanding History RNTX Shares Outstanding History RNXT Shares Outstanding History RPHM Shares Outstanding History RPID Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.